| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 25, 2022 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | CEO &Chairman | Sell | 5,662 | $1.75 | $9,908.50 | -0.8% | -27.5% | -28.7% | |
| Jul 22, 2022 | RMD Resmed Inc | Sandercock Brett63 | Chief Financial Officer | Sell | 7,500 | $235.00 | $1,762,500.00 | -6.6% | -6.0% | -4.7% | |
| Jul 22, 2022 | INCY Incyte Corp | Tray Thomas55 | Principal Accounting Officer | Sell | 1,564 | $83.13 | $130,015.32 | -8.1% | -14.8% | -20.7% | |
| Jul 22, 2022 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | VP, Global Human Resources | Sell | 252 | $17.85 | $4,498.20 | -0.8% | +5.0% | +13.1% | |
| Jul 22, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 5,200 | $8.02 | $41,709.20 | +0.3% | +7.0% | +33.5% | |
| Jul 22, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 367 | $17.94 | $6,583.98 | -0.9% | +5.0% | +13.1% | |
| Jul 21, 2022 | RGEN Repligen Corp | Hunt Anthony75 | Chief Executive Officer | Sell | 24,802 | $200.00 | $4,960,400.00 | -11.3% | -11.9% | -13.9% | |
| Jul 21, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 10,333 | $8.03 | $83,010.12 | +0.6% | +5.5% | +32.3% | |
| Jul 21, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 200 | $22.04 | $4,408.00 | - | -28.7% | -65.1% | |
| Jul 20, 2022 | ENOV Enovis Corp | Kleckner John62 | Principal Accounting Officer | Sell | 44 | $56.73 | $2,496.08 | -2.6% | -17.7% | +13.2% | |
| Jul 20, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 1,500 | $34.57 | $51,855.00 | -79.8% | +20.8% | +158.1% | |
| Jul 20, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 5,100 | $8.08 | $41,191.68 | +0.3% | +6.1% | +28.0% | |
| Jul 20, 2022 | RSCF Reflect Scientific, Inc. | Boyce Kim | CEO, CFO | Buy | 25,000 | $0.11 | $2,747.50 | - | - | - | |
| Jul 20, 2022 | DCTH Delcath Systems, Inc. | Michel Gerard J47 | Chief Executive Officer | Buy | 62,814 | $3.98 | $249,999.72 | +99.6% | -25.0% | +22.5% | |
| Jul 19, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 2,725 | $1.86 | $5,068.50 | -5.2% | -22.8% | +67.6% | |
| Jul 19, 2022 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $11.83 | $236,600.00 | -0.2% | +26.2% | -25.3% | |
| Jul 19, 2022 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 787 | $16.56 | $13,032.72 | -1.8% | -8.8% | +17.1% | |
| Jul 19, 2022 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | - | Sell | 34,200 | $16.10 | $550,670.55 | -0.9% | +44.7% | +48.5% | |
| Jul 18, 2022 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 63,466 | $3.72 | $236,093.52 | -6.9% | -17.6% | -42.6% | |
| Jul 18, 2022 | EKSO Ekso Bionics Holdings, Inc. | Wong Jerome55 | Interimchief Financial Officer | Sell | 98 | $1.71 | $167.13 | - | -14.5% | -20.2% | |
| Jul 18, 2022 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 7,500 | $38.00 | $285,000.00 | -5.7% | +9.9% | +42.1% | |
| Jul 16, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | 10% Owner | Buy | 263,002 | $2.35 | $617,986.04 | +1.6% | -17.4% | -21.3% | |
| Jul 15, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 30,000 | $17.37 | $521,137.14 | -2.2% | -19.3% | -58.9% | |
| Jul 15, 2022 | SIBN Si-Bone, Inc. | Dunn Jeffrey W | Director | Sell | 2,116 | $14.28 | $30,215.21 | -1.5% | +39.0% | +103.5% | |
| Jul 15, 2022 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $224.94 | $1,276,517.48 | -1.4% | -4.6% | -1.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.